Preemptive Analgesia for Postoperative Pain Control for Dental Treatment Under General Anesthesia
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03852602 |
|
Recruitment Status :
Completed
First Posted : February 25, 2019
Last Update Posted : June 14, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Pain, Postoperative | Drug: Preemptive Analgesics Drug: Control |
The investigator's study included patients who were admitted to Inonu University and Adnan Menderes University, Faculty of Dentistry, Department of Pediatric Dentistry in 2019 and decided to perform dental treatment under general anesthesia. Patients 1 to 7 years of age with dental treatment between February 28 and June 1, 2019 will be included.
Patients who underwent analgesic 15 minutes after the induction of general anesthesia from the patients, and those who made painkillers 15 minutes before the end of the treatment will constitute the control group. Paracetamol 15 mg / kg IV will be given in 50 ml of saline.
The demographic data of the children to be included in the study such as age, gender, type of dental intervention, duration of operation, postoperative pain scores, recovery times will be recorded and compared.
| Study Type : | Observational |
| Actual Enrollment : | 70 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Preemptive Analgesia for Postoperative Pain Control for Dental Treatment Under General Anesthesia in Children |
| Actual Study Start Date : | February 28, 2019 |
| Actual Primary Completion Date : | February 15, 2020 |
| Actual Study Completion Date : | March 30, 2020 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Group Control
Analgesic application15 minutes before the end of the treatment will constitute the control group.
|
Drug: Control
Analgesic application15 minutes before the end of the treatment
Other Name: Preventive analgesic |
|
Group preemptive
Patients who underwent analgesic 15 minutes after the induction of general anesthesia .
|
Drug: Preemptive Analgesics
Analgesic application15 minutes before the treatment |
- Postoperative dental pain [ Time Frame: An average of 24 hours postoperatively ]Wong-Baker faces Scale is validated for children aged 3 to 7 years, includes six cartoon faces corresponding to scores 0-5 (0=no hurt, 1= hurts a little bit, 2= hurts a little more, 3=hurts even more, 4= hurts a whole lot, 5=hurts worst).
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 3 Years to 7 Years (Child) |
| Sexes Eligible for Study: | All |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- To be treated under general anesthesia
- No systemic disease
- To have at least one painful dental procedure in the upper and lower jaw (pulpectomy, pulpotomy
Exclusion Criteria:
- Patients with mental or physical disabilities of any disease
- Patients who have not undergone painful dental intervention under general anesthesia
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03852602
| Turkey | |
| Sultan KELES | |
| Aydin, Turkey, 09100 | |
| Study Chair: | Sultan Keles, Dr. | Aydin Adnan Menderes University |
| Responsible Party: | Sultan KELES, Assist. Prof.Dr., Aydin Adnan Menderes University |
| ClinicalTrials.gov Identifier: | NCT03852602 |
| Other Study ID Numbers: |
2019-18 |
| First Posted: | February 25, 2019 Key Record Dates |
| Last Update Posted: | June 14, 2021 |
| Last Verified: | June 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Plan Description: | Study will be conducted and then will be published. |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Pain, Postoperative Postoperative Complications Pathologic Processes Pain Neurologic Manifestations |
Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs |

